Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-04

Clinical Trial Update: Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy [NA]

View source ↗

Summary

A clinical trial update indicates a partially hydrolyzed whey protein formula for infants with mild allergic symptoms is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Partially Hydrolyzed Whey Protein Formula (partially hydrolyzed whey protein formula)

Snippet

Sponsor: Ruijin Hospital | Conditions: Mild Allergic Symptoms in Infants, Infant Feeding Intolerance | NA | Status: NOT_YET_RECRUITING